Praxis Precision Medicines (PRAX) News Today $76.52 +3.68 (+5.05%) (As of 12/20/2024 05:45 PM ET) Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 Time Period Praxis Precision Medicines (PRAX) Gets a Buy from Truist FinancialDecember 20 at 9:33 PM | markets.businessinsider.comFranklin Resources Inc. Raises Stock Holdings in Praxis Precision Medicines, Inc. (NASDAQ:PRAX)Franklin Resources Inc. boosted its holdings in shares of Praxis Precision Medicines, Inc. (NASDAQ:PRAX - Free Report) by 85.6% in the third quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 445,233 shares of the company'sDecember 20 at 4:51 AM | marketbeat.comState Street Corp Sells 29,518 Shares of Praxis Precision Medicines, Inc. (NASDAQ:PRAX)State Street Corp lessened its holdings in shares of Praxis Precision Medicines, Inc. (NASDAQ:PRAX - Free Report) by 3.6% in the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 789,624 shares of the company's stocDecember 20 at 3:39 AM | marketbeat.comPraxis Precision Medicines, Inc.: Praxis Precision Medicines Announces Rare Pediatric Disease Designation Granted for Relutrigine in Dravet SyndromeDecember 18 at 4:25 PM | finanznachrichten.dePraxis Precision announces U.S. FDA granted RPDD for relutrigineDecember 18 at 4:25 PM | markets.businessinsider.comPraxis Precision Medicines Announces Rare Pediatric Disease Designation Granted for Relutrigine in Dravet SyndromeDecember 18 at 8:00 AM | globenewswire.comPraxis Precision Medicines (NASDAQ:PRAX) Sees Large Volume Increase - Here's What HappenedPraxis Precision Medicines (NASDAQ:PRAX) Sees Strong Trading Volume - Here's What HappenedDecember 16, 2024 | marketbeat.comPraxis Precision Medicines, Inc. (NASDAQ:PRAX) Shares Bought by Wellington Management Group LLPWellington Management Group LLP increased its stake in Praxis Precision Medicines, Inc. (NASDAQ:PRAX - Free Report) by 326.9% in the third quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 219,907 shares of the company's stock after buyiDecember 15, 2024 | marketbeat.comBNP Paribas Financial Markets Has $548,000 Stock Holdings in Praxis Precision Medicines, Inc. (NASDAQ:PRAX)BNP Paribas Financial Markets grew its position in Praxis Precision Medicines, Inc. (NASDAQ:PRAX - Free Report) by 369.4% during the 3rd quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 9,525 shares of the company's stock after purchasing an additionaDecember 14, 2024 | marketbeat.comPiper Sandler Sticks to Its Buy Rating for Praxis Precision Medicines (PRAX)December 12, 2024 | markets.businessinsider.comExpert Ratings For Praxis Precision MedicineDecember 12, 2024 | benzinga.comPromising Pipeline and Strategic Developments Position Praxis Precision Medicines for Market ExpansionDecember 12, 2024 | markets.businessinsider.comPraxis Precision Medicines' (PRAX) Buy Rating Reiterated at HC WainwrightHC Wainwright reaffirmed a "buy" rating and issued a $120.00 price objective on shares of Praxis Precision Medicines in a research report on Thursday.December 12, 2024 | marketbeat.comPraxis Precision Medicines, Inc. (NASDAQ:PRAX) Position Trimmed by Fmr LLCFmr LLC decreased its position in shares of Praxis Precision Medicines, Inc. (NASDAQ:PRAX - Free Report) by 5.9% in the 3rd quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 273,895 shares of the company's stock after selling 17,084 shares during theDecember 11, 2024 | marketbeat.comPraxis Precision Medicines, Inc. (NASDAQ:PRAX) Shares Bought by Charles Schwab Investment Management Inc.Charles Schwab Investment Management Inc. boosted its stake in Praxis Precision Medicines, Inc. (NASDAQ:PRAX - Free Report) by 188.7% in the third quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 137,052 shares of the compDecember 11, 2024 | marketbeat.comPraxis Precision Medicines, Inc. (NASDAQ:PRAX) Receives Average Recommendation of "Moderate Buy" from BrokeragesShares of Praxis Precision Medicines, Inc. (NASDAQ:PRAX - Get Free Report) have earned a consensus recommendation of "Moderate Buy" from the nine analysts that are currently covering the company, MarketBeat reports. One equities research analyst has rated the stock with a hold rating and eight havDecember 10, 2024 | marketbeat.comJacobs Levy Equity Management Inc. Sells 23,362 Shares of Praxis Precision Medicines, Inc. (NASDAQ:PRAX)Jacobs Levy Equity Management Inc. reduced its position in Praxis Precision Medicines, Inc. (NASDAQ:PRAX - Free Report) by 36.9% during the third quarter, according to its most recent 13F filing with the SEC. The firm owned 39,999 shares of the company's stock after selling 23,362 shares during theDecember 8, 2024 | marketbeat.comPraxis Precision Medicines, Inc. (NASDAQ:PRAX) Shares Acquired by Janus Henderson Group PLCJanus Henderson Group PLC lifted its position in Praxis Precision Medicines, Inc. (NASDAQ:PRAX - Free Report) by 37.2% during the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 523,566 shares of the company's stock aDecember 7, 2024 | marketbeat.comPraxis Precision Medicines, Inc. (NASDAQ:PRAX) Shares Sold by RA Capital Management L.P.RA Capital Management L.P. cut its stake in shares of Praxis Precision Medicines, Inc. (NASDAQ:PRAX - Free Report) by 38.3% during the 3rd quarter, according to its most recent filing with the SEC. The institutional investor owned 761,955 shares of the company's stock after selling 473,644 sharesDecember 5, 2024 | marketbeat.comPraxis Precision Medicines to Present at Upcoming December Investor ConferencesDecember 3, 2024 | globenewswire.comHighVista Strategies LLC Takes $630,000 Position in Praxis Precision Medicines, Inc. (NASDAQ:PRAX)HighVista Strategies LLC acquired a new position in Praxis Precision Medicines, Inc. (NASDAQ:PRAX - Free Report) in the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor acquired 10,951 shares of the coDecember 3, 2024 | marketbeat.comWalleye Capital LLC Buys Shares of 55,613 Praxis Precision Medicines, Inc. (NASDAQ:PRAX)Walleye Capital LLC purchased a new position in Praxis Precision Medicines, Inc. (NASDAQ:PRAX - Free Report) during the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor purchased 55,613 shares of theDecember 3, 2024 | marketbeat.comBaker BROS. Advisors LP Purchases 191,572 Shares of Praxis Precision Medicines, Inc. (NASDAQ:PRAX)Baker BROS. Advisors LP raised its holdings in shares of Praxis Precision Medicines, Inc. (NASDAQ:PRAX - Free Report) by 145.6% during the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 323,105 shares of the comDecember 2, 2024 | marketbeat.comFred Alger Management LLC Increases Stock Holdings in Praxis Precision Medicines, Inc. (NASDAQ:PRAX)Fred Alger Management LLC raised its position in Praxis Precision Medicines, Inc. (NASDAQ:PRAX - Free Report) by 301.7% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 10,423 shares of thDecember 2, 2024 | marketbeat.comVerition Fund Management LLC Sells 189,169 Shares of Praxis Precision Medicines, Inc. (NASDAQ:PRAX)Verition Fund Management LLC trimmed its position in Praxis Precision Medicines, Inc. (NASDAQ:PRAX - Free Report) by 25.3% during the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 559,151 shares of the company'November 29, 2024 | marketbeat.comAlly Bridge Group NY LLC Sells 80,194 Shares of Praxis Precision Medicines, Inc. (NASDAQ:PRAX)Ally Bridge Group NY LLC trimmed its holdings in shares of Praxis Precision Medicines, Inc. (NASDAQ:PRAX - Free Report) by 52.3% during the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 73,185 shares of the comNovember 28, 2024 | marketbeat.comPraxis Precision Medicines, Inc. (NASDAQ:PRAX) Shares Sold by Acuta Capital Partners LLCAcuta Capital Partners LLC lowered its stake in Praxis Precision Medicines, Inc. (NASDAQ:PRAX - Free Report) by 65.0% during the third quarter, according to its most recent 13F filing with the SEC. The firm owned 57,500 shares of the company's stock after selling 106,931 shares during the quarter.November 28, 2024 | marketbeat.comPraxis Precision Medicines, Inc. (PRAX)November 23, 2024 | finance.yahoo.comPraxis Precision Medicines (NASDAQ:PRAX) Shares Gap Down Following Insider SellingPraxis Precision Medicines (NASDAQ:PRAX) Shares Gap Down on Insider SellingNovember 18, 2024 | marketbeat.comCIBC Asset Management Inc Acquires 56,272 Shares of Praxis Precision Medicines, Inc. (NASDAQ:PRAX)CIBC Asset Management Inc lifted its holdings in Praxis Precision Medicines, Inc. (NASDAQ:PRAX - Free Report) by 29.2% in the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 248,939 shares of the company's stock aftNovember 17, 2024 | marketbeat.comInsider Selling: Praxis Precision Medicines, Inc. (NASDAQ:PRAX) Insider Sells 5,188 Shares of StockNovember 16, 2024 | insidertrades.comInsider Selling: Praxis Precision Medicines, Inc. (NASDAQ:PRAX) Insider Sells 5,188 Shares of StockPraxis Precision Medicines, Inc. (NASDAQ:PRAX - Get Free Report) insider Lauren Mastrocola sold 5,188 shares of the company's stock in a transaction on Thursday, November 14th. The shares were sold at an average price of $81.78, for a total transaction of $424,274.64. Following the completion of the sale, the insider now directly owns 5,613 shares in the company, valued at approximately $459,031.14. This represents a 48.03 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this link.November 15, 2024 | marketbeat.comAlex Nemiroff Sells 8,239 Shares of Praxis Precision Medicines, Inc. (NASDAQ:PRAX) StockPraxis Precision Medicines, Inc. (NASDAQ:PRAX - Get Free Report) General Counsel Alex Nemiroff sold 8,239 shares of the stock in a transaction dated Thursday, November 14th. The stock was sold at an average price of $80.20, for a total transaction of $660,767.80. Following the sale, the general counsel now owns 10,301 shares of the company's stock, valued at $826,140.20. This trade represents a 44.44 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website.November 15, 2024 | marketbeat.comPraxis Precision Medicines (NASDAQ:PRAX) Trading Down 7.9% - Should You Sell?Praxis Precision Medicines (NASDAQ:PRAX) Shares Down 7.9% - Time to Sell?November 15, 2024 | marketbeat.comPraxis Precision Medicines, Inc. (NASDAQ:PRAX) Given Average Rating of "Moderate Buy" by BrokeragesShares of Praxis Precision Medicines, Inc. (NASDAQ:PRAX - Get Free Report) have received a consensus rating of "Moderate Buy" from the nine brokerages that are currently covering the company, MarketBeat.com reports. One investment analyst has rated the stock with a hold rating and eight have assigNovember 15, 2024 | marketbeat.comPiper Sandler Gives a Buy Rating to Praxis Precision Medicines (PRAX)November 13, 2024 | markets.businessinsider.comFY2024 Earnings Estimate for PRAX Issued By HC WainwrightPraxis Precision Medicines, Inc. (NASDAQ:PRAX - Free Report) - Equities researchers at HC Wainwright reduced their FY2024 earnings estimates for Praxis Precision Medicines in a research report issued on Thursday, November 7th. HC Wainwright analyst D. Tsao now expects that the company will post eNovember 11, 2024 | marketbeat.comEquities Analysts Offer Predictions for PRAX FY2024 EarningsPraxis Precision Medicines, Inc. (NASDAQ:PRAX - Free Report) - Wedbush decreased their FY2024 earnings per share (EPS) estimates for Praxis Precision Medicines in a research note issued to investors on Wednesday, November 6th. Wedbush analyst L. Chico now anticipates that the company will post eaNovember 11, 2024 | marketbeat.comPraxis Precision Medicine (NASDAQ:PRAX) Stock, Insider Trading ActivityNovember 8, 2024 | benzinga.comPraxis Precision Medicine (NASDAQ:PRAX) Stock, Short Interest ReportNovember 8, 2024 | benzinga.comPraxis Precision Medicines: Strong Buy Rating Amid Potential Upside and Robust Pipeline Despite Operational ChallengesNovember 8, 2024 | markets.businessinsider.comPraxis Precision Medicines Third Quarter 2024 Earnings: Revenues Beat Expectations, EPS LagsNovember 8, 2024 | finance.yahoo.comOptimistic Buy Rating for Praxis Precision Medicines Amid Strategic Pipeline Advancements and Long-term Growth PotentialNovember 7, 2024 | markets.businessinsider.comQ3 2024 Praxis Precision Medicines Inc Earnings CallNovember 7, 2024 | finance.yahoo.comPraxis Precision Medicines Reports Q3 2024 Results and ProgressNovember 7, 2024 | markets.businessinsider.comPraxis Precision Medicines (NASDAQ:PRAX) Given "Buy" Rating at Needham & Company LLCNeedham & Company LLC restated a "buy" rating and set a $151.00 price target on shares of Praxis Precision Medicines in a report on Thursday.November 7, 2024 | marketbeat.comPraxis Precision Medicines' (PRAX) Buy Rating Reaffirmed at HC WainwrightHC Wainwright reiterated a "buy" rating and set a $120.00 target price on shares of Praxis Precision Medicines in a research report on Thursday.November 7, 2024 | marketbeat.comPraxis Precision Medicines to Participate in Three Upcoming November Investor ConferencesNovember 6, 2024 | globenewswire.comPraxis Precision Medicines, Inc. (PRAX) Q3 2024 Earnings Call TranscriptNovember 6, 2024 | seekingalpha.comPraxis Precision Medicines Provides Corporate Update and Reports Third Quarter 2024 Financial ResultsNovember 6, 2024 | globenewswire.com Get Praxis Precision Medicines News Delivered to You Automatically Sign up to receive the latest news and ratings for PRAX and its competitors with MarketBeat's FREE daily newsletter. Email Address Could This Tiny Device Help You Make an Extra $30k a Year? (Ad)I believe it’s going to power Elon Musk’s next AI revolution… A revolution he believes will be worth more than $9 trillion. That’s nearly 10 times more money than the market caps of Tesla… SpaceX… PayPal… Neuralink… and X… COMBINED. Click here to see the details because I believe a lot of people will get rich. PRAX Media Mentions By Week PRAX Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. PRAX News Sentiment▼0.960.60▲Average Medical News Sentiment PRAX News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. PRAX Articles This Week▼84▲PRAX Articles Average Week Get Praxis Precision Medicines News Delivered to You Automatically Sign up to receive the latest news and ratings for PRAX and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies BridgeBio Pharma News Today Crinetics Pharmaceuticals News Today Krystal Biotech News Today Arcellx News Today ADMA Biologics News Today Ultragenyx Pharmaceutical News Today Apellis Pharmaceuticals News Today Biohaven News Today Immunovant News Today Avidity Biosciences News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:PRAX) was last updated on 12/21/2024 by MarketBeat.com Staff From Our PartnersAmazon coin set to soar 25X – starting December 16th?This tiny 3-cent crypto just partnered with one of the biggest companies in the world… Amazon. And one team...True Market Insiders | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode before 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Praxis Precision Medicines, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Praxis Precision Medicines With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
